Government officials in Guinea-Bissau have formally rejected a clinical trial that would be run by Danish researchers and funded by the US to look for alleged nonspecific harms from the newborn dose of the hepatitis B vaccine. The vaccine dose is currently recommended globally for all newborns and has been used safely and effectively for decades.
In an email to Ars Technica, one of the trial’s lead researchers, Christine Stabell Benn of Bandim Health Project and the University of Southern Denmark, said that Guinea-Bissau’s Council of Ministers “formally reaffirmed its non-acceptance of the study on 16 October.”
The revelation that the study was formally rejected last week comes after news on Monday that judicial police in Guinea-Bissau raided Bandim Health’s offices and seized vaccines. Stabell Benn highlighted that the police search came after the trial was rejected.
Crows can evaluate visual info twice as fast as mammals
October 23, 2026
Intel gets waiver after worries fuzzy US ban on foreign-made robots may hit fabs
October 23, 2026
RFK Jr.’s vaccine injury clinic could damage NIH hospital, board warns
October 23, 2026
Knicks sent employees fake offer of championship rings in phishing test: Report
October 23, 2026
Everybody panic: A Valve developer said "HLX" in public
October 23, 2026
The reactor meant to showcase nuclear’s comeback keeps hitting problems
October 23, 2026
Fangs For The Memories: The Best Vampires In Video Games
October 23, 2026
Leave It To Double Fine To Make The First Single-Player Friendslop Game
October 23, 2026
Call Of Duty: Modern Warfare 4’s First DLC Is Out Now, Honors A Real Soldier Who Sustained Gruesome Injuries
October 23, 2026
புதினிடம் கெஞ்சிய டிரம்ப்.. 40,000 மெட்ரிக் டன் டீசலை அமெரிக்காவிற்கு அனுப்பி வைத்த ரஷ்யா! பின்னணி
October 23, 2026
Shepard Actor Reacts To Leaked Mass Effect Trailer, Is “Holding Hope” The Game Will Live On
October 23, 2026
Green councillors face Labour deadline to disown Zionism policy
October 23, 2026